Mitochondrial acetylation and genetic models of parkinson's disease

Progress in Molecular Biology and Translational Science

Volumn 127, Issue , 2014, Pages 155-182

  Auburger, Georg ^a   Gispert, Suzana ^a   Jendrach, Marina ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Alpha Synuclein; Deacylases; Mitochondrial lysine acetylation; Mitophagy; PARKIN; Parkinson's disease; PINK1; Respiratory complex V; SIRT3

Indexed keywords

LYSINE; MITOCHONDRIAL PROTEIN; PARKIN; PINK1 PROTEIN; SILENT INFORMATION REGULATOR PROTEIN; SIRTUIN; SIRTUIN 3; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; AUTOPHAGY; BIOENERGY; DEACETYLATION; GENE MUTATION; GENETIC MODEL; HUMAN; LONGEVITY; MITOCHONDRION; MITOPHAGY; MOLECULAR PATHOLOGY; MOUSE MODEL; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; BIOLOGICAL MODEL; ENERGY METABOLISM; GENETICS; METABOLISM; PATHOLOGY;

ACETYLATION; ANIMALS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MODELS, GENETIC; PARKINSON DISEASE;

EID: 84906656472     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394625-6.00006-4     Document Type: Chapter

References (133)

1. J. Vijg, and J. Campisi Puzzles, promises and a cure for ageing Nature 454 7208 2008 1065 1071
2. M. Kaeberlein, M. McVey, and L. Guarente The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms Genes Dev 13 19 1999 2570 2580 (Pubitemid 29489648)
3. H.A. Tissenbaum, and L. Guarente Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 6825 2001 227 230 (Pubitemid 32216597)
4. S. Imai, C.M. Armstrong, M. Kaeberlein, and L. Guarente Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 6771 2000 795 800 (Pubitemid 30111843)
5. M.D. Hirschey, T. Shimazu, J.Y. Huang, B. Schwer, and E. Verdin SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism Cold Spring Harb Symp Quant Biol 76 2011 267 277
6. K.T. Howitz, K.J. Bitterman, and H.Y. Cohen et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 6954 2003 191 196 (Pubitemid 37150899)
7. G. Rizki, T.N. Iwata, and J. Li et al. The evolutionarily conserved longevity determinants HCF-1 and SIR-2.1/SIRT1 collaborate to regulate DAF-16/FOXO PLoS Genet 7 9 2011 e1002235
8. A.H. Tseng, S.S. Shieh, and D.L. Wang SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage Free Radic Biol Med 63 2013 222 234
9. D. Frescas, L. Valenti, and D. Accili Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes J Biol Chem 280 21 2005 20589 20595 (Pubitemid 40776761)
10. A. van der Horst, L.G. Tertoolen, L.M. de Vries-Smits, R.A. Frye, R.H. Medema, and B.M. Burgering FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1) J Biol Chem 279 28 2004 28873 28879 (Pubitemid 38915754)
11. M.C. Motta, N. Divecha, and M. Lemieux et al. Mammalian SIRT1 represses forkhead transcription factors Cell 116 4 2004 551 563 (Pubitemid 38264432)
12. K. Schmeisser, J. Mansfeld, and D. Kuhlow et al. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide Nat Chem Biol 9 11 2013 693 700
13. M.D. Hirschey Old enzymes, new tricks: sirtuins are NAD(+)-dependent de-acylases Cell Metab 14 6 2011 718 719
14. L. Guarente Sirtuins, aging, and metabolism Cold Spring Harb Symp Quant Biol 76 2011 81 90
15. I.H. Lee, L. Cao, and R. Mostoslavsky et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy Proc Natl Acad Sci U S A 105 9 2008 3374 3379 (Pubitemid 351723560)
16. T.L. Kawahara, E. Michishita, and A.S. Adler et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span Cell 136 1 2009 62 74
17. H. Jiang, S. Khan, and Y. Wang et al. SIRT6 regulates TNF-alpha secretion through hydrolysis of long-chain fatty acyl lysine Nature 496 7443 2013 110 113
18. M.F. Barber, E. Michishita-Kioi, and Y. Xi et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation Nature 487 7405 2012 114 118
19. G. Ramakrishnan, G. Davaakhuu, and L. Kaplun et al. Sirt2 deacetylase is a novel AKT binding partner critical for AKT activation by insulin J Biol Chem 289 9 2014 6054 6066
20. B.J. North, B.L. Marshall, M.T. Borra, J.M. Denu, and E. Verdin The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase Mol Cell 11 2 2003 437 444 (Pubitemid 36293837)
21. M.M. Maxwell, E.M. Tomkinson, and J. Nobles et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS Hum Mol Genet 20 20 2011 3986 3996
22. E.L. Bell, and L. Guarente The SirT3 divining rod points to oxidative stress Mol Cell 42 5 2011 561 568
23. T.F. Outeiro, E. Kontopoulos, and S.M. Altmann et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease Science 317 5837 2007 516 519 (Pubitemid 47196116)
24. P. Wareski, A. Vaarmann, and V. Choubey et al. PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons J Biol Chem 284 32 2009 21379 21385
25. J.E. Duda, B.I. Giasson, and M.E. Mabon et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred Acta Neuropathol 104 1 2002 7 11 (Pubitemid 36075353)
26. C.M. Lill, J.T. Roehr, and M.B. McQueen et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database PLoS Genet 8 3 2012 e1002548
27. L. Kang, M.K. Janowska, G.M. Moriarty, and J. Baum Mechanistic insight into the relationship between N-terminal acetylation of alpha-synuclein and fibril formation rates by NMR and fluorescence PLoS One 8 9 2013 e75018
28. I. Dikiy, and D. Eliezer N-terminal acetylation stabilizes N-terminal helicity in lipid- and micelle-bound alpha-synuclein and increases its affinity for physiological membranes J Biol Chem 289 6 2014 3652 3665
29. S.W. Min, S.H. Cho, and Y. Zhou et al. Acetylation of tau inhibits its degradation and contributes to tauopathy Neuron 67 6 2010 953 966
30. M.C. Haigis, R. Mostoslavsky, and K.M. Haigis et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells Cell 126 5 2006 941 954 (Pubitemid 44321935)
31. J. Du, Y. Zhou, and X. Su et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase Science 334 6057 2011 806 809
32. J.C. Newman, W. He, and E. Verdin Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease J Biol Chem 287 51 2012 42436 42443
33. T. Shi, F. Wang, E. Stieren, and Q. Tong SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes J Biol Chem 280 14 2005 13560 13567 (Pubitemid 40517248)
34. I.R. Lanza, D.K. Short, and K.R. Short et al. Endurance exercise as a countermeasure for aging Diabetes 57 11 2008 2933 2942
35. O.M. Palacios, J.J. Carmona, and S. Michan et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle Aging (Albany NY) 1 9 2009 771 783
36. M.D. Hirschey, T. Shimazu, and E. Goetzman et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation Nature 464 7285 2010 121 125
37. E. Jing, B. Emanuelli, and M.D. Hirschey et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production Proc Natl Acad Sci U S A 108 35 2011 14608 14613
38. P.W. Caton, M.J. Holness, D. Bishop-Bailey, and M.C. Sugden PPARalpha-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status Biochem J 437 3 2011 521 530
39. M.D. Hirschey, T. Shimazu, and E. Jing et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome Mol Cell 44 2 2011 177 190
40. J. Bao, I. Scott, and Z. Lu et al. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity Free Radic Biol Med 49 7 2010 1230 1237
41. X. Kong, R. Wang, and Y. Xue et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis PLoS One 5 7 2010 e11707
42. H.Y. Cohen, C. Miller, and K.J. Bitterman et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase Science 305 5682 2004 390 392 (Pubitemid 38938153)
43. D. Chen, J. Bruno, and E. Easlon et al. Tissue-specific regulation of SIRT1 by calorie restriction Genes Dev 22 13 2008 1753 1757 (Pubitemid 351915500)
44. S. Hayashida, A. Arimoto, and Y. Kuramoto et al. Fasting promotes the expression of SIRT1, an NAD+-dependent protein deacetylase, via activation of PPARalpha in mice Mol Cell Biochem 339 1-2 2010 285 292
45. S. Ghosh, S. George, U. Roy, D. Ramachandran, and U. Kolthur-Seetharam NAD: a master regulator of transcription Biochim Biophys Acta 1799 10-12 2010 681 693
46. C.B. Peek, A.H. Affinati, and K.M. Ramsey et al. Circadian clock NAD + cycle drives mitochondrial oxidative metabolism in mice Science 342 6158 2013 1243417
47. E. Koltai, Z. Szabo, and M. Atalay et al. Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats Mech Ageing Dev 131 1 2010 21 28
48. H. Yang, T. Yang, and J.A. Baur et al. Nutrient-sensitive mitochondrial NAD + levels dictate cell survival Cell 130 6 2007 1095 1107 (Pubitemid 47410271)
49. B. Schwer, M. Eckersdorff, and Y. Li et al. Calorie restriction alters mitochondrial protein acetylation Aging Cell 8 5 2009 604 606
50. N. Nasrin, X. Wu, and E. Fortier et al. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells J Biol Chem 285 42 2010 31995 32002
51. T. Fujino, J. Kondo, M. Ishikawa, K. Morikawa, and T.T. Yamamoto Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate J Biol Chem 276 14 2001 11420 11426 (Pubitemid 38089336)
52. H. Sone, H. Shimano, and Y. Sakakura et al. Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status Am J Physiol Endocrinol Metab 282 1 2002 E222 E230
53. B.T. Weinert, S.A. Wagner, and H. Horn et al. Proteome-wide mapping of the Drosophila acetylome demonstrates a high degree of conservation of lysine acetylation Sci Signal 4 183 2011 ra48
54. I. Scott, B.R. Webster, J.H. Li, and M.N. Sack Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1 Biochem J 443 3 2012 655 661
55. S.P. Baker, and P.A. Grant The SAGA continues: expanding the cellular role of a transcriptional co-activator complex Oncogene 26 37 2007 5329 5340 (Pubitemid 47255919)
56. E.L. Bell, B.M. Emerling, S.J. Ricoult, and L. Guarente SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production Oncogene 30 26 2011 2986 2996
57. X. Qiu, K. Brown, M.D. Hirschey, E. Verdin, and D. Chen Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation Cell Metab 12 6 2010 662 667
58. R. Tao, M.C. Coleman, and J.D. Pennington et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress Mol Cell 40 6 2010 893 904
59. H.S. Kim, K. Patel, and K. Muldoon-Jacobs et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress Cancer Cell 17 1 2010 41 52
60. L.W. Finley, A. Carracedo, and J. Lee et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization Cancer Cell 19 3 2011 416 428
61. K.H. Huang, C.C. Hsu, and W.L. Fang et al. SIRT3 expression as a biomarker for better prognosis in gastric cancer World J Surg 2013
62. B. Yang, X. Fu, L. Shao, Y. Ding, and D. Zeng Aberrant expression of SIRT3 is conversely correlated with the progression and prognosis of human gastric cancer Biochem Biophys Res Commun 443 1 2014 156 160
63. H. Li, Z. Feng, W. Wu, J. Li, J. Zhang, and T. Xia SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2 Int J Oncol 43 5 2013 1420 1430
64. K. Xiao, J. Jiang, and W. Wang et al. Sirt3 is a tumor suppressor in lung adenocarcinoma cells Oncol Rep 30 3 2013 1323 1328
65. B. Zhang, L. Qin, C.J. Zhou, Y.L. Liu, H.X. Qian, and S.B. He SIRT3 expression in hepatocellular carcinoma and its impact on proliferation and invasion of hepatoma cells Asian Pac J Trop Med 6 8 2013 649 652
66. C.Z. Zhang, L. Liu, and M. Cai et al. Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma PLoS One 7 12 2012 e51703
67. C.C. Lai, P.M. Lin, and S.F. Lin et al. Altered expression of SIRT gene family in head and neck squamous cell carcinoma Tumour Biol 34 3 2013 1847 1854
68. R. Shackelford, S. Hirsh, K. Henry, A. Abdel-Mageed, E. Kandil, and D. Coppola Nicotinamide phosphoribosyltransferase and SIRT3 expression are increased in well-differentiated thyroid carcinomas Anticancer Res 33 8 2013 3047 3052
69. N. Ashraf, S. Zino, and A. Macintyre et al. Altered sirtuin expression is associated with node-positive breast cancer Br J Cancer 95 8 2006 1056 1061 (Pubitemid 44606833)
70. T.Y. Alhazzazi, P. Kamarajan, E. Verdin, and Y.L. Kapila SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 1816 1 2011 80 88
71. B.R. Webster, I. Scott, and K. Han et al. Restricted mitochondrial protein acetylation initiates mitochondrial autophagy J Cell Sci 126 Pt 21 2013 4843 4849
72. I. Scott, B.R. Webster, C.K. Chan, J.U. Okonkwo, K. Han, and M.N. Sack GCN5-like protein 1 (GCN5L1) controls mitochondrial content through coordinated regulation of mitochondrial biogenesis and mitophagy J Biol Chem 289 5 2014 2864 2872
73. P. Guedes-Dias, and J.M. Oliveira Lysine deacetylases and mitochondrial dynamics in neurodegeneration Biochim Biophys Acta 1832 8 2013 1345 1359
74. E. Deas, N.W. Wood, and H. Plun-Favreau Mitophagy and Parkinson's disease: the PINK1-Parkin link Biochim Biophys Acta 1813 4 2011 623 633
75. W.X. Ding, and X.M. Yin Mitophagy: mechanisms, pathophysiological roles, and analysis Biol Chem 393 7 2012 547 564
76. A.J. Whitworth, and L.J. Pallanck The PINK1/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomembr 41 6 2009 499 503
77. J.M. Tan, E.S. Wong, and D.S. Kirkpatrick et al. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases Hum Mol Genet 17 3 2008 431 439
78. S. Geisler, K.M. Holmstrom, and D. Skujat et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 Nat Cell Biol 12 2 2010 119 131
79. S.A. Sarraf, M. Raman, and V. Guarani-Pereira et al. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization Nature 496 7445 2013 372 376
80. J.Y. Lee, H. Koga, and Y. Kawaguchi et al. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy EMBO J 29 5 2010 969 980
81. J.Y. Lee, Y. Nagano, J.P. Taylor, K.L. Lim, and T.P. Yao Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy J Cell Biol 189 4 2010 671 679
82. R.L. de Vries, and S. Przedborski Mitophagy and Parkinson's disease: be eaten to stay healthy Mol Cell Neurosci 55 2013 37 43
83. W. Springer, and P.J. Kahle Regulation of PINK1-Parkin-mediated mitophagy Autophagy 7 3 2011 266 278
84. G.K. Tofaris Lysosome-dependent pathways as a unifying theme in Parkinson's disease Mov Disord 27 11 2012 1364 1369
85. L.J. Pallanck Culling sick mitochondria from the herd J Cell Biol 191 7 2010 1225 1227
86. M. Klinkenberg, S. Gispert, J.A. Dominguez-Bautista, I. Braun, G. Auburger, and M. Jendrach Restriction of trophic factors and nutrients induces PARKIN expression Neurogenetics 13 1 2012 9 21
87. S. Mai, M. Klinkenberg, G. Auburger, J. Bereiter-Hahn, and M. Jendrach Decreased expression of Drp1 and Fis1 mediates mitochondrial elongation in senescent cells and enhances resistance to oxidative stress through PINK1 J Cell Sci 123 Pt 6 2010 917 926
88. E.M. Valente, P.M. Abou-Sleiman, and V. Caputo et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 5674 2004 1158 1160 (Pubitemid 38661852)
89. L. Silvestri, V. Caputo, and E. Bellacchio et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive Parkinsonism Hum Mol Genet 14 22 2005 3477 3492 (Pubitemid 41672130)
90. D. Becker, J. Richter, M.A. Tocilescu, S. Przedborski, and W. Voos Pink1 kinase and its membrane potential (Deltapsi)-dependent cleavage product both localize to outer mitochondrial membrane by unique targeting mode J Biol Chem 287 27 2012 22969 22987
91. T. Kitada, S. Asakawa, and N. Hattori et al. Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism Nature 392 6676 1998 605 608 (Pubitemid 28207717)
92. O. Corti, S. Lesage, and A. Brice What genetics tells us about the causes and mechanisms of Parkinson's disease Physiol Rev 91 4 2011 1161 1218
93. A. Petit, T. Kawarai, and E. Paitel et al. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations J Biol Chem 280 40 2005 34025 34032 (Pubitemid 41443124)
94. H.H. Hoepken, S. Gispert, and B. Morales et al. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6 Neurobiol Dis 25 2 2007 401 411 (Pubitemid 46124020)
95. A. Grunewald, M.E. Gegg, and J.W. Taanman et al. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology Exp Neurol 219 1 2009 266 273
96. A.Y. Abramov, M. Gegg, A. Grunewald, N.W. Wood, C. Klein, and A.H. Schapira Bioenergetic consequences of PINK1 mutations in Parkinson disease PLoS One 6 10 2011 e25622
97. N. Exner, B. Treske, and D. Paquet et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by Parkin J Neurosci 27 45 2007 12413 12418 (Pubitemid 350085485)
98. M. Klinkenberg, N. Thurow, and S. Gispert et al. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress Neuroscience 166 2 2010 422 434
99. O. Corti, and A. Brice Mitochondrial quality control turns out to be the principal suspect in Parkin and PINK1-related autosomal recessive Parkinson's disease Curr Opin Neurobiol 23 1 2013 100 108
100. A. Rakovic, A. Grunewald, and J. Kottwitz et al. Mutations in PINK1 and Parkin impair ubiquitination of mitofusins in human fibroblasts PLoS One 6 3 2011 e16746
101. A. Rakovic, A. Grunewald, and P. Seibler et al. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients Hum Mol Genet 19 16 2010 3124 3137
102. P. Seibler, J. Graziotto, H. Jeong, F. Simunovic, C. Klein, and D. Krainc Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells J Neurosci 31 16 2011 5970 5976
103. A. Rakovic, K. Shurkewitsch, and P. Seibler et al. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons J Biol Chem 288 4 2013 2223 2237
104. J.C. Greene, A.J. Whitworth, I. Kuo, L.A. Andrews, M.B. Feany, and L.J. Pallanck Mitochondrial pathology and apoptotic muscle degeneration in Drosophila Parkin mutants Proc Natl Acad Sci U S A 100 7 2003 4078 4083 (Pubitemid 36418160)
105. I.E. Clark, M.W. Dodson, and C. Jiang et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with Parkin Nature 441 7097 2006 1162 1166 (Pubitemid 43990738)
106. J. Park, S.B. Lee, and S. Lee et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by Parkin Nature 441 7097 2006 1157 1161 (Pubitemid 43990737)
107. M.S. Goldberg, S.M. Fleming, and J.J. Palacino et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons J Biol Chem 278 44 2003 43628 43635 (Pubitemid 37345989)
108. F.A. Perez, and R.D. Palmiter Parkin-deficient mice are not a robust model of Parkinsonism Proc Natl Acad Sci U S A 102 6 2005 2174 2179 (Pubitemid 40262031)
109. J.M. Itier, P. Ibanez, and M.A. Mena et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse Hum Mol Genet 12 18 2003 2277 2291 (Pubitemid 37160872)
110. R. Von Coelln, B. Thomas, and J.M. Savitt et al. Loss of locus coeruleus neurons and reduced startle in Parkin null mice Proc Natl Acad Sci U S A 101 29 2004 10744 10749 (Pubitemid 38955813)
111. T. Kitada, A. Pisani, and D.R. Porter et al. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice Proc Natl Acad Sci U S A 104 27 2007 11441 11446 (Pubitemid 47175159)
112. S. Gandhi, A. Vaarmann, Z. Yao, M.R. Duchen, N.W. Wood, and A.Y. Abramov Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease PLoS One 7 5 2012 e37564
113. S. Gispert, F. Ricciardi, and A. Kurz et al. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration PLoS One 4 6 2009 e5777
114. N. Dehorter, N. Lozovaya, and B.J. Mdzomba et al. Subthalamic lesion or levodopa treatment rescues giant GABAergic currents of PINK1-deficient striatum J Neurosci 32 50 2012 18047 18053
115. X.R. Zhu, L. Maskri, and C. Herold et al. Non-motor behavioural impairments in Parkin-deficient mice Eur J Neurosci 26 7 2007 1902 1911 (Pubitemid 47493196)
116. C.C. Stichel, X.R. Zhu, V. Bader, B. Linnartz, S. Schmidt, and H. Lubbert Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage Hum Mol Genet 16 20 2007 2377 2393 (Pubitemid 47514484)
117. S. Schmidt, B. Linnartz, and S. Mendritzki et al. Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria Hum Mol Genet 20 6 2011 1197 1211
118. M.H. Polymeropoulos, C. Lavedan, and E. Leroy et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 5321 1997 2045 2047 (Pubitemid 27443610)
119. A.B. Singleton, M. Farrer, and J. Johnson et al. Apha-synuclein locus triplication causes Parkinson's disease Science 302 5646 2003 841 (Pubitemid 37339619)
120. F. Kamp, N. Exner, and A.K. Lutz et al. Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1 EMBO J 29 20 2010 3571 3589
121. A.M. Todd, and B.E. Staveley Expression of Pink1 with alpha-synuclein in the dopaminergic neurons of Drosophila leads to increases in both lifespan and healthspan Genet Mol Res 11 2 2012 1497 1502
122. H.H. Hoepken, S. Gispert, and M. Azizov et al. Parkinson patient fibroblasts show increased alpha-synuclein expression Exp Neurol 212 2 2008 307 313
123. L. Samaranch, O. Lorenzo-Betancor, and J.M. Arbelo et al. PINK1-linked Parkinsonism is associated with Lewy body pathology Brain 133 Pt 4 2010 1128 1142
124. W. Liu, C. Vives-Bauza, and R. Acin-Perez et al. PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease PLoS One 4 2 2009 e4597
125. J. Burre, M. Sharma, T. Tsetsenis, V. Buchman, M.R. Etherton, and T.C. Sudhof Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro Science 329 5999 2010 1663 1667
126. S. Gispert, D. Del Turco, and L. Garrett et al. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation Mol Cell Neurosci 24 2 2003 419 429 (Pubitemid 37311305)
127. A. Kurz, K.L. Double, and I. Lastres-Becker et al. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice PLoS One 5 7 2010 e11464
128. A. Tozzi, C. Costa, and S. Siliquini et al. Mechanisms underlying altered striatal synaptic plasticity in old A53T-alpha synuclein overexpressing mice Neurobiol Aging 33 8 2012 1792 1799
129. A. Kurz, C. May, and O. Schmidt et al. A53T-alpha-synuclein- overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP J Neural Transm 119 3 2012 297 312
130. N.J. Platt, S. Gispert, G. Auburger, and S.J. Cragg Striatal dopamine transmission is subtly modified in human A53Talpha-synuclein overexpressing mice PLoS One 7 5 2012 e36397
131. P.A. Agarwal, and A.J. Stoessl Biomarkers for trials of neuroprotection in Parkinson's disease Mov Disord 28 1 2013 71 85
132. L. Parnetti, A. Castrioto, and D. Chiasserini et al. Cerebrospinal fluid biomarkers in Parkinson disease Nat Rev Neurol 9 3 2013 131 140
133. I. Ferrer, I. Lopez-Gonzalez, M. Carmona, E. Dalfo, A. Pujol, and A. Martinez Neurochemistry and the non-motor aspects of PD Neurobiol Dis 46 3 2012 508 526